サマリー

産業用水処理装置の世界市場 2022-2026 年
Technavioは産業用水処理装置市場を監視しており、2022-2026年の間に84億8000万ドルの成長が見込まれ、予測期間中にCAGR 4.47%で加速しています。当レポートでは、工業用水処理装置市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、水不足と環境問題の高まり、発展途上国における急速な工業化、厳格な汚染防止プログラムなどが要因となっています。
産業用水処理装置市場の分析には、エンドユーザーセグメントや地理的状況も含まれます。
Technavioの産業用水処理装置市場は、以下のように区分されています。
エンドユーザー別
- エネルギー・電力
- 製造業
- その他
地域別
- APAC
- 欧州
- 北アメリカ
- 中近東・アフリカ
- 南米
本調査では、水処理技術の革新が、今後数年間の工業用水処理装置市場の成長を促進する主要な理由の1つであると特定しています。また、工業用水処理とスマート廃水処理管理のための光触媒水処理プロセスの研究は、市場のかなりの需要につながるでしょう。
Technavioは、複数のソースからのデータの研究、合成、主要パラメータの分析による総括の方法により、市場の詳細な姿を提示します。産業用水処理装置市場に関する弊社のレポートは、以下の分野を対象としています。
- 工業用水処理装置市場のサイジング
- 工業用水処理装置市場の予測
- 工業用水処理装置市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、産業用水処理装置市場の主要ベンダー（3M社、Aquatech International LLC、Calgon Carbon Corp、Culligan International Co、Danaher Corp、DuPont de Nemours Inc、Ecolab Inc、Evoqua Water Technologies LLC、General Electric Co、Clita Water Industries Ltd., Lamor Corp.、Lenntech BV、Prc.Plc、Lenntech BV、Organo Corp.、Pentair Plc、Robert B. Hill Co.、Samco Technologies Inc、SUEZ WTS USA Inc、Terex Corp、Veolia Environment SA、Xylem Inc.の各社があります。また、産業用水処理装置市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/industrial-water-treatment-equipment-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 21: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 22: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 23: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 24: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Route of Administration
o 5.1 Market segments
o Exhibit 25: Chart on Route of Administration - Market share 2021-2026 (%)
o Exhibit 26: Data Table on Route of Administration - Market share 2021-2026 (%)
o 5.2 Comparison by Route of Administration
o Exhibit 27: Chart on Comparison by Route of Administration
o Exhibit 28: Data Table on Comparison by Route of Administration
o 5.3 Oral - Market size and forecast 2021-2026
o Exhibit 29: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 31: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 32: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.4 Topical - Market size and forecast 2021-2026
o Exhibit 33: Chart on Topical - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
o Exhibit 35: Chart on Topical - Year-over-year growth 2021-2026 (%)
o Exhibit 36: Data Table on Topical - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Route of Administration
o Exhibit 37: Market opportunity by Route of Administration ($ million)
• 6 Market Segmentation by Drug Class
o 6.1 Market segments
o Exhibit 38: Chart on Drug Class - Market share 2021-2026 (%)
o Exhibit 39: Data Table on Drug Class - Market share 2021-2026 (%)
o 6.2 Comparison by Drug Class
o Exhibit 40: Chart on Comparison by Drug Class
o Exhibit 41: Data Table on Comparison by Drug Class
o 6.3 SSRIs - Market size and forecast 2021-2026
o Exhibit 42: Chart on SSRIs - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on SSRIs - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on SSRIs - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on SSRIs - Year-over-year growth 2021-2026 (%)
o 6.4 PDE5 inhibitors - Market size and forecast 2021-2026
o Exhibit 46: Chart on PDE5 inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on PDE5 inhibitors - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on PDE5 inhibitors - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on PDE5 inhibitors - Year-over-year growth 2021-2026 (%)
o 6.5 Amide anesthetics - Market size and forecast 2021-2026
o Exhibit 50: Chart on Amide anesthetics - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Amide anesthetics - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Amide anesthetics - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Amide anesthetics - Year-over-year growth 2021-2026 (%)
o 6.6 Others - Market size and forecast 2021-2026
o Exhibit 54: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 6.7 Market opportunity by Drug Class
o Exhibit 58: Market opportunity by Drug Class ($ million)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Geographic Landscape
o 8.1 Geographic segmentation
o Exhibit 60: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 61: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 8.2 Geographic comparison
o Exhibit 62: Chart on Geographic comparison
o Exhibit 63: Data Table on Geographic comparison
o 8.3 North America - Market size and forecast 2021-2026
o Exhibit 64: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 66: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 67: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 8.4 Europe - Market size and forecast 2021-2026
o Exhibit 68: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 69: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 70: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 71: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 8.5 Asia - Market size and forecast 2021-2026
o Exhibit 72: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 73: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 74: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 75: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 8.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 8.7 US - Market size and forecast 2021-2026
o Exhibit 80: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 81: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 82: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 83: Data Table on US - Year-over-year growth 2021-2026 (%)
o 8.8 Italy - Market size and forecast 2021-2026
o Exhibit 84: Chart on Italy - Market size and forecast 2021-2026 ($ million)
o Exhibit 85: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
o Exhibit 86: Chart on Italy - Year-over-year growth 2021-2026 (%)
o Exhibit 87: Data Table on Italy - Year-over-year growth 2021-2026 (%)
o 8.9 China - Market size and forecast 2021-2026
o Exhibit 88: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 89: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 90: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 91: Data Table on China - Year-over-year growth 2021-2026 (%)
o 8.10 UK - Market size and forecast 2021-2026
o Exhibit 92: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 93: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 94: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 95: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 8.11 India - Market size and forecast 2021-2026
o Exhibit 96: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 97: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 98: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 99: Data Table on India - Year-over-year growth 2021-2026 (%)
o 8.12 Market opportunity By Geographical Landscape
o Exhibit 100: Market opportunity By Geographical Landscape ($ million)
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2021 and 2026
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 105: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 11.3 Absorption Pharmaceuticals LLC
o Exhibit 107: Absorption Pharmaceuticals LLC - Overview
o Exhibit 108: Absorption Pharmaceuticals LLC - Product / Service
o Exhibit 109: Absorption Pharmaceuticals LLC - Key offerings
o 11.4 Alembic Pharmaceuticals Inc.
o Exhibit 110: Alembic Pharmaceuticals Inc. - Overview
o Exhibit 111: Alembic Pharmaceuticals Inc. - Product / Service
o Exhibit 112: Alembic Pharmaceuticals Inc. - Key offerings
o 11.5 Amneal Pharmaceuticals Inc.
o Exhibit 113: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 114: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 115: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 116: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 117: Amneal Pharmaceuticals Inc. - Segment focus
o 11.6 Bayer AG
o Exhibit 118: Bayer AG - Overview
o Exhibit 119: Bayer AG - Business segments
o Exhibit 120: Bayer AG - Key offerings
o Exhibit 121: Bayer AG - Segment focus
o 11.7 Cipla Ltd.
o Exhibit 122: Cipla Ltd. - Overview
o Exhibit 123: Cipla Ltd. - Business segments
o Exhibit 124: Cipla Ltd. - Key news
o Exhibit 125: Cipla Ltd. - Key offerings
o Exhibit 126: Cipla Ltd. - Segment focus
o 11.8 Eli Lilly and Co.
o Exhibit 127: Eli Lilly and Co. - Overview
o Exhibit 128: Eli Lilly and Co. - Product / Service
o Exhibit 129: Eli Lilly and Co. - Key offerings
o 11.9 Pfizer Inc.
o Exhibit 130: Pfizer Inc. - Overview
o Exhibit 131: Pfizer Inc. - Product / Service
o Exhibit 132: Pfizer Inc. - Key news
o Exhibit 133: Pfizer Inc. - Key offerings
o 11.10 Sandoz International GmbH
o Exhibit 134: Sandoz International GmbH - Overview
o Exhibit 135: Sandoz International GmbH - Product / Service
o Exhibit 136: Sandoz International GmbH - Key news
o Exhibit 137: Sandoz International GmbH - Key offerings
o 11.11 Solco Healthcare
o Exhibit 138: Solco Healthcare - Overview
o Exhibit 139: Solco Healthcare - Product / Service
o Exhibit 140: Solco Healthcare - Key offerings
o 11.12 Teva Pharmaceutical Industries Ltd.
o Exhibit 141: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 142: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 143: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 144: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 145: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 146: Inclusions checklist
o Exhibit 147: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 148: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 149: Research methodology
o Exhibit 150: Validation techniques employed for market sizing
o Exhibit 151: Information sources
o 12.5 List of abbreviations
o Exhibit 152: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits18: Five forces analysis - Comparison between 2021 and 2026
Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits21: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits22: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits23: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits24: Chart on Market condition - Five forces 2021 and 2026
Exhibits25: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits27: Chart on Comparison by Route of Administration
Exhibits28: Data Table on Comparison by Route of Administration
Exhibits29: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits30: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits31: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits32: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits33: Chart on Topical - Market size and forecast 2021-2026 ($ million)
Exhibits34: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
Exhibits35: Chart on Topical - Year-over-year growth 2021-2026 (%)
Exhibits36: Data Table on Topical - Year-over-year growth 2021-2026 (%)
Exhibits37: Market opportunity by Route of Administration ($ million)
Exhibits38: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits39: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits40: Chart on Comparison by Drug Class
Exhibits41: Data Table on Comparison by Drug Class
Exhibits42: Chart on SSRIs - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on SSRIs - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on SSRIs - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on SSRIs - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on PDE5 inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on PDE5 inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on PDE5 inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on PDE5 inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Amide anesthetics - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Amide anesthetics - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Amide anesthetics - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Amide anesthetics - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits58: Market opportunity by Drug Class ($ million)
Exhibits59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits60: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits61: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits62: Chart on Geographic comparison
Exhibits63: Data Table on Geographic comparison
Exhibits64: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits66: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits67: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits68: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits69: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits70: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits71: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits72: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits73: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits74: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits75: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits80: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits81: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits82: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits83: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits84: Chart on Italy - Market size and forecast 2021-2026 ($ million)
Exhibits85: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
Exhibits86: Chart on Italy - Year-over-year growth 2021-2026 (%)
Exhibits87: Data Table on Italy - Year-over-year growth 2021-2026 (%)
Exhibits88: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits89: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits90: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits91: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits92: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits93: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits94: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits95: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits96: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits97: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits98: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits99: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits100: Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2021 and 2026
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Absorption Pharmaceuticals LLC - Overview
Exhibits108: Absorption Pharmaceuticals LLC - Product / Service
Exhibits109: Absorption Pharmaceuticals LLC - Key offerings
Exhibits110: Alembic Pharmaceuticals Inc. - Overview
Exhibits111: Alembic Pharmaceuticals Inc. - Product / Service
Exhibits112: Alembic Pharmaceuticals Inc. - Key offerings
Exhibits113: Amneal Pharmaceuticals Inc. - Overview
Exhibits114: Amneal Pharmaceuticals Inc. - Business segments
Exhibits115: Amneal Pharmaceuticals Inc. - Key news
Exhibits116: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits117: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits118: Bayer AG - Overview
Exhibits119: Bayer AG - Business segments
Exhibits120: Bayer AG - Key offerings
Exhibits121: Bayer AG - Segment focus
Exhibits122: Cipla Ltd. - Overview
Exhibits123: Cipla Ltd. - Business segments
Exhibits124: Cipla Ltd. - Key news
Exhibits125: Cipla Ltd. - Key offerings
Exhibits126: Cipla Ltd. - Segment focus
Exhibits127: Eli Lilly and Co. - Overview
Exhibits128: Eli Lilly and Co. - Product / Service
Exhibits129: Eli Lilly and Co. - Key offerings
Exhibits130: Pfizer Inc. - Overview
Exhibits131: Pfizer Inc. - Product / Service
Exhibits132: Pfizer Inc. - Key news
Exhibits133: Pfizer Inc. - Key offerings
Exhibits134: Sandoz International GmbH - Overview
Exhibits135: Sandoz International GmbH - Product / Service
Exhibits136: Sandoz International GmbH - Key news
Exhibits137: Sandoz International GmbH - Key offerings
Exhibits138: Solco Healthcare - Overview
Exhibits139: Solco Healthcare - Product / Service
Exhibits140: Solco Healthcare - Key offerings
Exhibits141: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits142: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits143: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits144: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits145: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits146: Inclusions checklist
Exhibits147: Exclusions checklist
Exhibits148: Currency conversion rates for US$
Exhibits149: Research methodology
Exhibits150: Validation techniques employed for market sizing
Exhibits151: Information sources
Exhibits152: List of abbreviations